Asset Details
Do you wish to reserve the book?
Impact of insulin resistance and metabolic syndrome on disability in patients with multiple sclerosis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Impact of insulin resistance and metabolic syndrome on disability in patients with multiple sclerosis
Do you wish to request the book?
Impact of insulin resistance and metabolic syndrome on disability in patients with multiple sclerosis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Impact of insulin resistance and metabolic syndrome on disability in patients with multiple sclerosis
2020
Overview
BackgroundCurrently, little is known regarding the association of metabolic comorbidities and disability among multiple sclerosis (MS) patients.ObjectivesTo evaluate insulin resistance (IR) and metabolic syndrome (MetS) in multiple sclerosis patients and their effect on disease progression and disability.Subjects and methodsThis case-control study was conducted on 50 MS patients and 25 healthy individuals. They were subjected to clinical evaluation and laboratory assessment for metabolic syndrome and insulin resistance. The homeostasis model assessment (HOMA) was used as a measurement of insulin sensitivity. Disability was evaluated by the Extended Disability Status Scale (EDSS).ResultsAs compared to control group, MS patients had a significantly higher prevalence of metabolic syndrome (22% vs 8%, p = 0.04) and insulin resistance (46% vs 0%, p < 0.001). Patients group had significantly higher systolic blood pressure (p = 0.005), waist circumference (p < 0.001), fasting blood sugar (p < 0.001), insulin level (p = 0.001), low-density lipoproteins (p = 0.01), triglycerides (p = 0.02), HOMA-IR (p < 0.001), and significantly lower high-density lipoproteins (p = 0.01). No differences in neurological disability was reported between patients who have MetS (p = 0.7) or IR (p = 0.3) and those who do not.ConclusionInsulin resistance and metabolic syndrome are more prevalent among MS patients; however, their association with disability and disease progression is questionable.
Publisher
Springer Nature B.V
Subject
